V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250007043 | 250004962 | 1.69 | 76 | Curative (C) | 2016-05-06 | 2016-05-29 | PEG INTERFERON | N | N | 250031012 | ANAGRELIDE |
| 250007044 | 250004963 | 1.65 | null | Curative (C) | null | 2016-05-22 | ANAGRELIDE | N | N | 250031015 | RUXOLITINIB |
| 250007045 | 250004964 | null | null | Disease modification (D) | 2017-03-05 | 2017-03-21 | RUXOLITINIB | N | null | 250031019 | RUXOLITINIB |
| 250007046 | 250009654 | 1.68 | 63 | null | 2017-09-05 | 2017-09-05 | RUXOLITINIB | N | N | 250031023 | RUXOLITINIB |
| 250007047 | 250004965 | 1.67 | null | null | 2013-08-05 | 2013-08-06 | Rituximab | 02 | N | 250031024 | AZACITIDINE |
| 250007048 | 250004966 | null | 63 | Adjuvant (A) | 2016-06-17 | 2016-06-17 | AML16 Azacitidine | 01 | N | 250031030 | RUXOLITINIB |
| 250007049 | 250004966 | 1.64 | null | null | 2016-03-22 | 2016-03-24 | Rituximab | 02 | N | 250031030 | RUXOLITINIB |
| 250007050 | 250004967 | 0 | 75.2 | Disease modification (D) | 2016-03-14 | 2016-03-16 | RUXOLITINIB | N | N | 250031035 | RUXOLITINIB |
| 250007052 | 250004969 | null | null | Curative (C) | 2017-05-19 | 2017-05-22 | Azacitidine | 02 | N | 250031038 | TRIAL |
| 250007054 | 250004971 | 0 | 102.6 | Curative (C) | 2017-01-15 | 2017-01-17 | RUXOLITINIB | N | N | 250031046 | ANAGRELIDE |
| 250007055 | 250004972 | 0 | 80 | Palliative (P) | 2016-12-19 | 2016-12-28 | RUXOLITINIB | N | N | 250031048 | RUXOLITINIB |
| 250007056 | 250004973 | null | 45 | Palliative (P) | 2013-11-12 | 2013-11-12 | CHOP R - 21 days | 2 | null | 250031053 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 250007057 | 250004974 | 0 | 77 | Disease modification (D) | 2016-03-13 | 2016-03-15 | Rituximab | 2 | N | 250031056 | BENDAMUSTINE + RITUXIMAB |
| 250007058 | 250004975 | null | null | Palliative (P) | 2014-01-25 | 2014-01-25 | Azacitidine | N | N | 250031059 | AZACITIDINE |
| 250007059 | 250004976 | 1.71 | 107.3 | Palliative (P) | 2014-01-11 | 2014-01-12 | BENDAMUSTINE + RITUXIMAB | 02 | N | 250031060 | RUXOLITINIB |
| 250007061 | 250004978 | 1.81 | 68 | Disease modification (D) | 2016-05-15 | 2016-05-29 | Busulfan Oral | Y | N | 250031064 | BENDAMUSTINE + RITUXIMAB |
| 250007063 | 250004980 | 0 | 72 | Neo-adjuvant (N) | 2014-07-19 | 2014-07-19 | Bendamustine+Rituximab(Sub Courses) | N | N | 250031072 | RUXOLITINIB |
| 250007064 | 250004980 | 1.55 | 63.4 | null | 2018-02-09 | 2018-02-17 | PEG INTERFERON | 02 | N | 250031072 | AZACITIDINE |
| 250007065 | 250004981 | 1.71 | 0 | Adjuvant (A) | 2015-02-05 | 2015-02-05 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 250031075 | PEMETREXED |
| 250007066 | 250004982 | 1.74 | 83.8 | null | 2016-10-20 | 2016-10-20 | Rituximab | 2 | N | 250031081 | BUSULPHAN |
| 250007067 | 250004983 | null | 68.95 | Adjuvant (A) | 2015-05-01 | 2015-05-01 | Busulfan Oral | 1 | N | 250031082 | RUXOLITINIB |
| 250007068 | 250009657 | null | 98.3 | Palliative (P) | 2012-10-09 | 2014-12-04 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 250031085 | PEMETREXED |
| 250007069 | 250004984 | 0 | 59.8 | Palliative (P) | 2014-06-21 | 2014-06-28 | Azacitidine | 02 | N | 250031086 | CHOP R |
| 250007070 | 250004985 | null | null | Adjuvant (A) | 2015-01-10 | 2015-01-10 | Erlotinib | 02 | N | 250031087 | TRIAL |
| 250007071 | 250009658 | 1.74 | 69.6 | Disease modification (D) | 2013-09-27 | 2013-09-28 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 250031089 | VINORELBINE |
| 250007072 | 250004986 | 1.75 | 76.9 | Disease modification (D) | 2017-03-22 | 2017-03-22 | Azacitidine | N | N | 250031094 | AZACITIDINE |
| 250007073 | 250004987 | 1.69 | 0 | Curative (C) | 2014-05-23 | 2014-05-25 | Rituximab | N | N | 250031096 | RUXOLITINIB |
| 250007074 | 250004988 | 0 | 72 | Disease modification (D) | 2015-04-17 | 2015-04-27 | Rituximab (Maintenance) | 2 | N | 250031098 | RUXOLITINIB |
| 250007075 | 250004989 | 0 | 79 | Disease modification (D) | 2015-01-16 | 2015-01-16 | Rituximab | N | N | 250031099 | RITUXIMAB |
| 250007079 | 250004991 | null | null | Adjuvant (A) | 2014-04-06 | 2014-04-18 | RUXOLITINIB | Y | N | 250031113 | IBRUTINIB |
| 250007080 | 250004991 | null | 45 | Curative (C) | 2016-01-31 | 2016-02-09 | RUXOLITINIB | N | N | 250031113 | RUXOLITINIB |
| 250007081 | 250004992 | 1.69 | null | Curative (C) | 2018-09-24 | 2018-09-24 | ANAGRELIDE | 2 | Y | 250031120 | RUXOLITINIB |
| 250007082 | 250004993 | 1.8 | null | Palliative (P) | 2014-06-08 | 2014-07-31 | RUXOLITINIB | N | N | 250031125 | RUXOLITINIB |
| 250007083 | 250004993 | 1.8 | 92 | Disease modification (D) | 2017-10-01 | 2017-10-01 | RUXOLITINIB | N | N | 250031125 | CHOP R |
| 250007084 | 250004994 | 1.85 | 0 | Palliative (P) | 2013-06-28 | 2013-06-28 | RUXOLITINIB | N | N | 250031130 | RITUXIMAB |
| 250007085 | 250009662 | 1.7 | null | Palliative (P) | 2013-08-05 | 2013-08-12 | RUXOLITINIB | N | N | 250031133 | PEG INTERFERON |
| 250007086 | 250004995 | 1.74 | 51.4 | p | null | 2016-11-26 | IMATINIB | N | N | 250031143 | RITUXIMAB |
| 250007087 | 250004996 | 1.62 | 73 | Disease modification (D) | 2016-02-08 | 2016-03-22 | RUXOLITINIB | N | null | 250031144 | AZACITIDINE |
| 250007088 | 250004997 | 0 | 63.5 | Palliative (P) | 2015-12-09 | 2016-01-01 | LENALIDOMIDE | N | N | 250031157 | RITUXIMAB |
| 250007089 | 250004998 | null | 88.5 | Palliative (P) | 2013-12-03 | 2013-12-03 | Busulfan Oral | 02 | N | 250031159 | RITUXIMAB |
| 250007090 | 250004999 | 1.63 | 0 | Palliative (P) | 2017-12-01 | 2017-12-01 | IMATINIB | 02 | N | 250031161 | TRIAL |
| 250007091 | 250004999 | null | 62.5 | Palliative (P) | 2016-07-27 | 2016-08-03 | PEG INTERFERON | 02 | null | 250031161 | CHOP R |
| 250007092 | 250004999 | null | 58.2 | Curative (C) | null | 2016-09-29 | RUXOLITINIB | N | Y | 250031161 | RUXOLITINIB |
| 250007093 | 250005000 | null | 0 | Palliative (P) | 2014-04-14 | 2014-04-14 | RUXOLITINIB | 02 | N | 250031173 | TRIAL |
| 250007094 | 250005001 | 1.58 | 61 | Disease modification (D) | 2013-01-08 | 2013-01-08 | RUXOLITINIB | 02 | N | 250031174 | RUXOLITINIB |
| 250007095 | 250005002 | 1.79 | 84.9 | Palliative (P) | 2015-05-11 | 2015-09-13 | RUXOLITINIB | N | N | 250031175 | ANAGRELIDE |
| 250007096 | 250005003 | 1.52 | 81 | Palliative (P) | 2017-06-27 | 2017-07-07 | Alemtuzumab(INTRAVENOUS) | N | N | 250031177 | RUXOLITINIB |
| 250007097 | 250005004 | 1.65 | 80 | Palliative (P) | 2016-09-14 | 2016-09-28 | Pemetrexed | 01 | N | 250031182 | CARBOPLATIN |
| 250007098 | 250005004 | 1.75 | 51.4 | Curative (C) | 2013-07-30 | 2013-07-30 | RUXOLITINIB | N | Y | 250031182 | RUXOLITINIB |
| 250007099 | 250005005 | 0 | 0 | Curative (C) | 2016-11-27 | 2016-11-27 | RUXOLITINIB | 2 | N | 250031198 | CHOP R |